Bluejay Diagnostics (BJDX) Competitors $3.19 -0.09 (-2.74%) Closing price 04:00 PM EasternExtended Trading$3.07 -0.12 (-3.76%) As of 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. CHEK, XAIR, LFWD, MHUA, LYRA, POAI, PAVM, INBS, TNON, and DHAIShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Check-Cap (CHEK), Beyond Air (XAIR), Lifeward (LFWD), Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), Predictive Oncology (POAI), PAVmed (PAVM), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors Check-Cap Beyond Air Lifeward Meihua International Medical Technologies Lyra Therapeutics Predictive Oncology PAVmed Intelligent Bio Solutions Tenon Medical DIH Holding US Bluejay Diagnostics (NASDAQ:BJDX) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations. Does the media refer more to BJDX or CHEK? In the previous week, Bluejay Diagnostics had 6 more articles in the media than Check-Cap. MarketBeat recorded 8 mentions for Bluejay Diagnostics and 2 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.95 beat Bluejay Diagnostics' score of 0.56 indicating that Check-Cap is being referred to more favorably in the news media. Company Overall Sentiment Bluejay Diagnostics Positive Check-Cap Positive Which has more risk and volatility, BJDX or CHEK? Bluejay Diagnostics has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Is BJDX or CHEK more profitable? Check-Cap's return on equity of 0.00% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Bluejay DiagnosticsN/A -362.07% -299.10% Check-Cap N/A N/A N/A Which has higher valuation and earnings, BJDX or CHEK? Bluejay Diagnostics has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBluejay Diagnostics$250K19.01-$7.72M-$125.15-0.03Check-CapN/AN/A-$25.15M-$3.00-0.61 Do insiders and institutionals hold more shares of BJDX or CHEK? 18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 0.1% of Bluejay Diagnostics shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer BJDX or CHEK? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bluejay Diagnostics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryBluejay Diagnostics beats Check-Cap on 6 of the 11 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.75M$6.86B$6.02B$10.26BDividend YieldN/A1.16%5.66%4.69%P/E Ratio-0.0326.3385.3626.60Price / Sales19.01189.68583.50178.23Price / CashN/A22.0838.3262.20Price / Book0.315.1112.736.54Net Income-$7.72M$178.04M$3.30B$275.87M7 Day Performance107.14%-1.93%1.04%-1.32%1 Month Performance120.00%8.39%7.62%5.24%1 Year Performance-45.89%27.51%79.71%31.56% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.8181 of 5 stars$3.19-2.7%N/A-45.7%$4.75M$250K-0.039News CoverageGap DownCHEKCheck-Cap0.2086 of 5 stars$2.16+2.4%N/A+43.1%$12.64MN/A-0.7280Positive NewsAnalyst ForecastXAIRBeyond Air4.2092 of 5 stars$2.40-4.0%$11.00+358.5%-62.4%$12.57M$4.78M-0.2070LFWDLifeward2.4849 of 5 stars$0.78-2.6%$9.00+1,052.4%-73.0%$12.14M$24.43M-0.2560Analyst ForecastMHUAMeihua International Medical Technologies0.8607 of 5 stars$0.38-0.5%N/A-45.5%$12.12M$96.90M0.00620Analyst ForecastGap UpLYRALyra Therapeutics3.2708 of 5 stars$7.33-9.4%$100.00+1,263.9%-28.6%$12.04M$770K-0.2550Analyst ForecastGap DownPOAIPredictive Oncology1.153 of 5 stars$13.89-2.9%N/A+45.5%$10.55M$1.62M-4.5530Analyst ForecastPAVMPAVmed4.1228 of 5 stars$0.47+5.2%$20.00+4,128.3%-60.9%$10.37M$1.02M0.4190Analyst ForecastGap UpINBSIntelligent Bio Solutions1.2362 of 5 stars$1.14-0.4%N/A-26.1%$10.31M$3.05M-0.5510Positive NewsAnalyst ForecastTNONTenon Medical2.1173 of 5 stars$1.16-1.3%$5.50+376.2%-67.6%$10.26M$3.28M-0.048Analyst ForecastDHAIDIH Holding US1.1751 of 5 stars$0.21+3.8%N/A-87.8%$9.80M$64.47M-0.69N/AAnalyst Forecast Related Companies and Tools Related Companies Check-Cap Alternatives Beyond Air Alternatives Lifeward Alternatives Meihua International Medical Technologies Alternatives Lyra Therapeutics Alternatives Predictive Oncology Alternatives PAVmed Alternatives Intelligent Bio Solutions Alternatives Tenon Medical Alternatives DIH Holding US Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
